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Article
Volitional pursed lips breathing
in patients with stable chronic
obstructive pulmonary disease
improves exercise capacity
Surya P. Bhatt1, T.K. Luqman-Arafath2, Arun K. Gupta3, Anant Mohan2,
Jill C. Stoltzfus4, Tanujit Dey5, Sudip Nanda6 and Randeep Guleria2
Abstract
Pursed lips breathing (PLB) is usedby a proportionof patientswith chronic obstructive pulmonary disease (COPD)
to alleviate dyspnea. It is also commonly used in pulmonary rehabilitation.Data to support its use in patientswhodo
not spontaneously adopt PLB are limited.We performed this study to assess the acute effects of PLB on exercise
capacity in nonspontaneously PLB patients with stable COPD. We performed a randomized crossover study
comparing 6-minwalk test (6MWT) at baselinewithout PLBwith 6WMTusing volitional PLB. Spirometry,maximal
inspiratory and expiratory mouth pressures, and diaphragmatic excursion during tidal and vital capacity breathing
using B-mode ultrasonography were measured at baseline and after 10 min of PLB. A Visual Analog Scale (VAS)
assessed subjective breathlessness at rest, after 6MWT and after 6MWT with PLB. p  0.01 was considered
significant. Mean + SD age of patients was 53.1 + 7.4 years. Forced expiratory volume in 1second was
1.1+ 0.4 L/min (38.4+ 13.2% predicted). Compared with spontaneous breathing, all but one patient with PLB
showed a significant increment in 6MW distance (þ34.9+ 26.4 m; p¼ 0.002). There was a significant reduction
in respiratory rate post 6MWT with PLB compared with spontaneous breathing (4.4 + 2.8 per minute;
p ¼ 0.003). There was no difference in VAS scores. There was a significant correlation between improvement
in 6MWTdistance and increase in diaphragmatic excursion during forced breathing. The improvementwas greater
in patientswho had poorer baseline exercise performance. PLBhas an acute benefit on exercise capacity. Sustained
PLB or short bursts of PLB may improve exercise capacity in stable COPD.
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Introduction
Patients with chronic obstructive pulmonary disease
(COPD) in respiratory distress frequently use pursed
lips breathing (PLB) to alleviate dyspnea. Multiple
mechanisms might be responsible for this perceived
benefit, both at rest and on exertion. PLB at rest has
been shown in various studies to improve gas
exchange,1 increase efficiency of ventilation,2 and
reduce respiratory rate (RR).3 PLB might reduce
intrinsic positive end expiratory pressure (PEEP) by
a way of generating positive pressures at the mouth
and serving as a physiological extrinsic PEEP. By
slowing expiration, it decreases the tendency of the
airways to collapse by reducing the Bernoulli effect
created by airflow.4 Dyspnea on exertion is associated
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with the extent and rate of respiratory muscle contrac-
tion.5 Exercise also leads to dynamic hyperinflation in
patients with COPD.6 It is posited that PLB, by reduc-
ing the RR and therefore dynamic hyperinflation,
brings the diaphragm to a vantage position.7 Based
on these, PLB has been commonly used as a breathing
technique in pulmonary rehabilitation. However, data
to support its use in patients who do not spontaneously
adopt PLB are conflicting.3,7–9
The purpose of this study is to determine the effects
of volitional PLB on exercise capacity in patients with
COPD who did not spontaneously adopt PLB. In view
of conflicting reports of benefit in previous studies
using varying techniques, we also assessed its effects
on respiratory mechanics and dyspnea and sought to
identify which patients would benefit from PLB.
Methods
We conducted an open-labeled randomized crossover
study. A total of 14 patients with moderate-to-severe
stable COPD, defined as no exacerbations in the pre-
ceding 4 weeks, were recruited for the study, from an
outpatient pulmonary clinic at a single tertiary care
referral center. Diagnosis of COPD was based on the
characteristic findings on history and examination
with typical radiographic abnormalities and con-
firmed by pulmonary function tests (PFTs).10 Exacer-
bation was defined as two of the following: worsening
dyspnea, increased expectoration and increased puru-
lence of sputum.10 Baseline demographic variables
were obtained for all patients. Duration of disease,
as determined by total duration of symptoms, was
recorded. Active smokers were defined as having
smoked within the past 6 months. Patients with
comorbidities, such as diabetes mellitus, hyperten-
sion, congestive heart failure, tuberculosis, bronc-
hiectasis, and intercurrent respiratory illness, were
excluded. Those with physical limitations or comor-
bidities such as angina and peripheral vascular disease
which precluded them from performing a 6-min walk
test (6MWT) were also excluded. Measurements were
conducted in three phases.
In the first phase, the patients were subjected to
baseline spirometry.11 Maximal inspiratory (MIP) and
expiratory pressures (MEP) measured at the mouth
were recorded.10 The best of the three readings was
documented. Patients were instructed on how to apply
PLB according to standard guidelines.8,12 Patients
were directed to inhale through the nose with the
mouth closed and then exhale slowly over 4–6seconds
through pursed lips held in a whistling position with-
out cheek puffing or forceful expiration.12 PLB was
applied for 10 min at rest. At the end of 10 min, spiro-
metry, MIP, and MEP measurements were repeated.
In the second phase, the patients performed a
6MWT.10 A subjective measure of dyspnea was
recorded using a Visual Analog Scale (VAS), both
at the start and immediately after the 6MWT. Baseline
clinical variables, such as RR, blood pressure, and
oxygen saturation (SaO2), were noted. RR was also
measured in the first minute after completion of the
6MWT. Patients who spontaneously used PLB during
exercise or in the resting phase were to be excluded.
None of the patients recruited used PLB sponta-
neously, and hence all patients were included in the
study. The first 6MWT was also used as a practice
test. The patients then performed two more 6MWT
while applying PLB and without applying PLB. The
sequence of 6MWT with and without PLB was inter-
changed at random so that seven patients with PLB
performed the test first and seven without. This was
to minimize the learning effect that could confound
result interpretation. The randomization was done
by having alternate patients perform their first test
6-min walk distance (6MWD) without PLB, and the
rest perform their first test 6MWD with volitional
PLB. VAS score was documented at the start and
immediately after the 6MWT.
In the third phase, diaphragmatic movements were
assessed using real-time B-mode ultrasound in the
supine position using validated techniques.13 Dia-
phragmatic excursion during normal tidal and forced
vital capacity (FVC) maneuver breathing was mea-
sured by a single-blinded qualified radiologist (AKG).
A fixed skin position on the right lateral chest wall on
the anterior axillary line was chosen to obtain a long-
itudinal plane of the right hemidiaphragm, including
the maximal renal bipolar length. This allowed iden-
tification of the adjacent posterior aspect of the hemi-
diaphragm. A craniocaudal displacement line was
marked with a cursor at the midpoint of the kidney,
and excursion of the hemidiaphragm measured along
this line with another cursor at the same depth from
the transducer. Diaphragmatic excursion was mea-
sured both during the tidal breathing and during a vital
capacity maneuver.13 For each maneuver, at least
three satisfactory readings were taken. The better of
the two values that agreed the most was selected for
tidal breathing, and the best of the three efforts was
chosen for forced breathing. All measurements were
repeated after 10 min of PLB. All three phases were
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completed on the same day, with adequate rest in
between phases, as indicated by patients returning to
baseline VAS scores. An additional hour of rest was
provided in between phases after return to baseline.
Informed consent was obtained from all the patients.
Ethical clearance was obtained from the Institutional
Review Board.
Statistical methods
Descriptive data were recorded for all the patients.
Due to small sample size, nonparametric tests were
used for analyses. The mean values for tests
performed before and after application of PLB
(6WMD, VAS, respiratory mechanics, and ultrasound
measures) were compared using theWilcoxon signed-
rank test. Correlation was measured between the gra-
dients in 6MWT distance and VAS, and the change in
variables thought to significantly affect 6MWT dis-
tance and VAS scores [forced vital capacity (FVC),
forced expiratory volume in one second (FEV1),
FEV1/FVC, MIP, MEP, diaphragmatic excursion dur-
ing tidal and deep breathing and respiratory rate]
using nonparametric Spearman’s correlation test. In
view of the small sample size, a p value of 0.01 was
considered significant for all analyses. All analyses
were done using SPSS version 11.5 (SPSS Inc., Chi-
cago, Illinois, USA).
Results
The anthropometric, demographic, and baseline PFT
variables of the study population are given in Table 1.
A majority of patients were in Stages 3 and 4 accord-
ing to the global initiative for chronic obstructive lung
disease (GOLDCOPD) criteria.14 Most of the patients
were active smokers or had a history of chronic smok-
ing, as defined by at least 20 pack-years of smoking.
All four nonsmokers had a history of significant expo-
sure to biomass fuel.
Compared with the distance covered in 6MWT
without application of PLB, there was a significant
improvement in the 6MWD when PLB was used.
Figure 1 shows the effects for each of the 14 patients.
There was a significant reduction in RR after the
6MWT with PLB when compared with that without.
A marginal decline was seen in the subjective assess-
ment of dyspnea. This was however not statistically
significant. Eight patients showed a decrease in VAS
score, whereas 1 showed no change. Table 2 shows the
effect of PLB on PFT parameters. When effects of
delta change in respiratory test parameters with
application of PLB on the improvement in 6MWD
were assessed, there was a good correlation with the
change in forced diaphragmatic excursion with 6MWD
(r ¼ 0.58, p ¼ 0.03; see Figure 2). We observed that
patients with worse functional capacity showed a visi-
bly larger increase in diaphragmatic excursion after
PLB. When only patients with Stages 3 and 4 COPD
were analyzed (n¼ 10), there was a greater correlation
between change in diaphragmatic excursion on deep
breathing and the improvement in 6MWD (r ¼ 0.78,
p ¼ 0.008). There was also a negative correlation
between the improvement in 6MWD and the baseline
6MWD (r ¼ 0.80, p ¼ 0.0007; see Figure 3).
Discussion
We found that applying PLB in nonspontaneously
PLB patients with COPD can increase exercise capac-
ity. There was a marginal decrease in subjective sense
of dyspnea. We also showed a decrease in the RR in
the recovery period after exercise with PLB.
COPD is a progressive airway disease with few
interventions that significantly improve quality of
life. Despite widespread use of PLB in pulmonary
rehabilitation, few studies have actually shown
consistent benefit in imposing PLB in patients who
do not already use it for relief.7,9,15 Our study is the
first to almost uniformly demonstrate an improvement
Table 1. Baseline demographic characteristics.a
Variable n ¼ 14
Age (years) 53.1+ 7.4 (range 45–70)
Sex (% males) 10 (71)
Median disease duration (years) 3 (range 1–8)
Smoker
Current 5
Ex 5
No 4
Pack-years 19 (0–72)
FEV1/FVC 48.9+10.8
FEV1 (L) 1.09 + 0.4
FEV1% 38.4 + 13.2
GOLDCOPD stage
I 0
II 4
III 5
IV 5
FEV1: forced expiratory volume in 1second; FVC: forced vital
capacity; GOLDCOPD: global initiative for chronic obstructive
lung disease to improve awareness and care of chronic obstruc-
tive pulmonary disease.
a Values are expressed as mean+ SD or in absolute numbers.
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in functional exercise tolerance with PLB. Increase in
functional exercise tolerance means a reduced work
of breathing for the same level of effort effectively
reducing the sense of dyspnea. This, however, proba-
bly comes at the cost of increased diaphragmatic
activity leading to a sense of increase in the muscle
activity, counterbalancing the subjective perception
of reduced dyspnea.16 This could explain the rela-
tively modest improvement in dyspnea scores in our
and prior studies.
The effect on dyspnea has not been uniform across
studies. This implies that there are responders and
nonresponders within this class of nonspontaneous
PLB patients. Identification of responders will be
valuable in exercise prescriptions. Bianchi et al.
assessed the effect of PLB on subjective sense of dys-
pnea using the Borg score and sought to explain this
by a change in operational lung volume, using optoe-
lectronic plethysmography.7 They found that Borg
score variability was significantly affected by a
decrease in end expiratory volume of the chest wall.
Spahija et al. demonstrated the variability in dyspnea
perception with change in the end expiratory lung
volume and the inspiratory muscle strength, using
plethysmography and esophageal balloons.8 There
was however a divergent response to PLB in their
Figure 1. Comparison of 6MWD before and after PLB. X axis denotes individual patients. PLB: pursed lips breathing;
6MWD: 6-min walk distance.
Table 2. Lung function studiesa
Pre-PLB Post-PLB p Valuea
FEV1 (L) 1.09 + 0.4 1.17+ 0.45 0.55
FEV1% 38.43 + 13.2 41.29+ 14.64 0.47
FVC (L) 2.22 + 0.67 2.21+ 0.70 0.29
FEV1/FVC 48.93 + 10.84 52.29+ 10.07 0.61
MMFR (L) 0.59 + 0.26 0.72+ 0.43 0.61
MIP (mmHg) 77.29 + 20.0 74.64+ 17.84 0.48
MEP (mmHg) 74.0 + 22.96 76.36+ 22.26 0.25
Tidal excursion (cm) 2.01 + 0.71 2.23+ 0.57 0.12
Forced excursion (cm) 4.13 + 1.94 4.63+ 1.43 0.14
6MWD (m)c 410.11+ 89.85 445.04+ 72.31 0.002
VAS after 6MWT (mm) 30.86 + 0.68 28.036+ 18.85 0.38
RR after 6MWT (per minute)c 23.5 + 3.25 19.29+ 4.90 0.002
FEV1: forced expiratory volume in 1second; FVC: forced vital capacity; MMFR: midmaximal flow rate; MIP: maximal inspiratory pressure;
MEP: maximal expiratory pressure, 6MWD: 6-min walk distance; VAS: Visual Analog Scale; 6MWT: 6-min walk test; RR: respiratory
rate; PLB: pursed lips breathing.
a All values are expressed as mean + SD.
b p value calculated using Wilcoxon signed-rank test.
c p  0.01.
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patient cohort. Garrod et al. could not show any
change in dyspnea perception or in 6MWD.3 In con-
trast to these studies, we sought to identify responders
to volitional application of PLB. After PLB, the delta
change in forced diaphragmatic excursion correlated
significantly with change in 6MWD. Deep breathing
is more likely to be reflective of diaphragmatic func-
tion during exercise or respiratory distress. This might
be a novel noninvasive way of identifying responders
to PLB, although small numbers precluded us from
defining cutoff values.
In our patients, there was a marginal reduction in
subjective perception of dyspnea as indicated by the
VAS. In fact, 8 of the 14 patients perceived a benefit
and one showed no change. No single factor can
possibly explain these changes. There was a signif-
icant decline in the RR during the recovery phase
from the 6MWT at which time the VAS was
marked. This is novel as most previous studies of
PLB showed reduction in RR while applying PLB
during recovery.1–3,7,8,17–19 Although this would
occur by the nature of instructions for PLB, we
showed that the RR is decreased in the period
immediately after exertion with PLB. Hyperinfla-
tion is greater during periods of exertion because
the increased frequency of breathing unfortunately
results in proportionally reduced expiratory time
leading to further air trapping and the onset of a
vicious cycle. Slower controlled breathing during
PLB reduces the rate and interrupts this cycle. This
might translate into a lesser central neural drive, a
lesser dissociation between actual ventilatory sig-
nals and the perceived effort (neuroventilatory dis-
sociation), and a lesser perception of dyspnea.20
Grandevia has shown that PLB leads to a 20%
increase in expired lung volume compared with a
forced expiration, thereby reducing air trapping.21
The reduction in hyperinflation by reduction in the
end expiratory lung volume results in an improved
ability to increase the tidal volume for a given
effort.6 The reduced RR also possibly allows more
time for V/Q matching.1 The results of our study
further refine the studies supporting the benefit of
PLB in advanced COPD.1,3,9
Our study was limited by the small number of
patients. We sought to alleviate this by applying a
more stringent p value (0.01) for statistical signifi-
cance. We did not directly measure the end expiratory
lung volume and trans-diaphragmatic pressures
generated to explain the changes. However, this is the
first study to document diaphragmatic movement
during PLB in real time by ultrasonography.
In summary, PLB increases functional exercise tol-
erance. This effect could be mediated by a reduction
in RR and increased diaphragmatic movement.
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